Literature DB >> 16836033

Medical care of adults with mental retardation.

Christopher D Prater1, Robert G Zylstra.   

Abstract

Persons with mental retardation are living longer and integrating into their communities. Primary medical care of persons with mental retardation should involve continuity of care, maintenance of comprehensive treatment documentation, routine periodic health screening, and an understanding of the unique medical and behavioral disorders common to this population. Office visits can be successful if physicians familiarize patients with the office and staff, plan for difficult behaviors, and administer mild sedation when appropriate. Some syndromes that cause mental retardation have specific medical and behavioral features. Health issues in these patients include respiratory problems, gastrointestinal disorders, challenging behaviors, and neurologic conditions. Some commonly overlooked health concerns are sexuality, sexually transmitted diseases, and end-of-life decisions.

Entities:  

Mesh:

Year:  2006        PMID: 16836033

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  4 in total

1.  Obsessive Compulsive Disorder with Intellectual Disability: A Diagnostic and Therapeutic Challenge.

Authors:  Priyanka Gautam; M S Bhatia
Journal:  J Clin Diagn Res       Date:  2015-09-01

2.  Caregiver awareness of reproductive health issues for women with intellectual disabilities.

Authors:  Lan-Ping Lin; Pei-Ying Lin; Shang-Wei Hsu; Ching-Hui Loh; Jin-Ding Lin; Chia-Im Lai; Wu-Chien Chien; Fu-Gong Lin
Journal:  BMC Public Health       Date:  2011-01-28       Impact factor: 3.295

3.  Is There Anything to Smile about? A Review of Oral Care for Individuals with Intellectual and Developmental Disabilities.

Authors:  Kathleen Fisher
Journal:  Nurs Res Pract       Date:  2012-02-28

Review 4.  Adults with intellectual disabilities and mental health disorders in primary care: a scoping review.

Authors:  Katrien Pm Pouls; Monique Cj Koks-Leensen; Mathilde Mastebroek; Geraline L Leusink; Willem Jj Assendelft
Journal:  Br J Gen Pract       Date:  2022-02-24       Impact factor: 5.386

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.